fda ruling on tirzepatide Lilly's new drug Mounjaro (tirzepatide ) wins US approval F.D.A. Approves New Obesity Drug

Just 1 scoop(6g) a daymix easily into water, shakes, or your favorite beverage,30 minutes before meals

Weight-loss ads are everywhere, and testimonials are often hosted directly on company websites, making it difficult to know which experiences are genuine.

A growing number of patients claim popular weight loss and diabetes drugs like Ozempic can cause a rare but very serious side effect they were never warned abou

Wegovy (semaglutide) Injector 1.7 mg/0.75 mL, 4 Pens Per Box is a medication used for chronic weight management in adults with obesity or excess weight who have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol. It is used in combination with a reduced calorie diet and increased physical activity. Wegovy is a glucagon-like peptide-1 (GLP-1) receptor antagonist and works by slowing down digestion, decreasing appetite, and increasing feelings of fullness, which helps with weight loss. It is administered as a subcutaneous injection and comes in a package of 4 pens for 4 weeks of treatment

Stopping GLP-1 medications like semaglutide before surgery requires careful timing and medical coordination

You asked